https://www.selleckchem.com/pr....oducts/Perifosine.ht
05). Among all patients, those with low LMR, HER-2 positive, and lymph node status (N2-3) demonstrated poor DFS. Our study thus demonstrated that LMR can act as a potential marker for predicting the efficacy and prognosis of patients with breast cancer. Our study thus demonstrated that LMR can act as a potential marker for predicting the efficacy and prognosis of patients with breast cancer. Gastric cancer (GC) is the fifth most frequently diagnosed cancer and the third leading cause of cancer-related death. There is a critical need
Like
Comment
Share
